Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

AMRITA KRISHNAN

Allopathic & Osteopathic Physicians Internal Medicine Hematology

NPI
1215948690
CMS profile
100883
Location
DUARTE, CA

General Payments · PY2018–2024

$711,142.53

  • Reported across 427 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$110,481.26

28 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $98,176.00 10
Travel and Lodging $10,903.68 5
Food and Beverage $1,401.58 13

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
GlaxoSmithKline, LLC. $86,450.00 4
F. Hoffmann-La Roche AG $14,304.31 6
Janssen Research & Development, LLC $4,298.14 2
ABBVIE INC. $3,575.00 3
GENZYME CORPORATION $831.00 1
Janssen Biotech, Inc. $354.51 4
Acerta Pharma LLC $338.35 3
PFIZER INC. $170.72 2
Legend Biotech USA Inc. $99.23 2
AstraZeneca UK Limited $60.00 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $147,751.93 145
PY2019 $100,097.55 81
PY2020 $67,281.85 33
PY2021 $87,071.39 46
PY2022 $83,995.08 58
PY2023 $114,463.47 36
PY2024 $110,481.26 28

Payment records · PY2024 (28)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $2,200.00 01/10/2024 Consulting Fee Undisputed 01/23/2026 1103136469 CMS
ABBVIE INC. $275.00 02/07/2024 Consulting Fee Undisputed 01/23/2026 1103136471 CMS
ABBVIE INC. $1,100.00 08/14/2024 Consulting Fee Undisputed 01/23/2026 1103136473 CMS
AstraZeneca Pharmaceuticals LP $103.44 08/08/2024 Food and Beverage Undisputed 01/23/2026 1105743190 CMS
AstraZeneca Pharmaceuticals LP $99.91 09/05/2024 Food and Beverage Undisputed 01/23/2026 1104524218 CMS
AstraZeneca Pharmaceuticals LP $135.00 12/09/2024 Food and Beverage Undisputed 01/23/2026 1105356627 CMS
AstraZeneca UK Limited $60.00 12/07/2024 Food and Beverage Undisputed 01/23/2026 1093994429 CMS
F. Hoffmann-La Roche AG $3,040.00 01/29/2024 Consulting Fee Undisputed 01/23/2026 1132975479 CMS
F. Hoffmann-La Roche AG $424.12 04/23/2024 Travel and Lodging Undisputed 01/23/2026 1132975481 CMS
F. Hoffmann-La Roche AG $9,453.10 04/23/2024 Travel and Lodging Undisputed 01/23/2026 1132975483 CMS
F. Hoffmann-La Roche AG $155.62 04/23/2024 Travel and Lodging Undisputed 01/23/2026 1132975485 CMS
F. Hoffmann-La Roche AG $386.13 04/23/2024 Food and Beverage Undisputed 01/23/2026 1132975487 CMS
F. Hoffmann-La Roche AG $845.34 04/23/2024 Travel and Lodging Undisputed 01/23/2026 1132975489 CMS
GENZYME CORPORATION $831.00 05/21/2024 Consulting Fee Undisputed 01/23/2026 1139624991 CMS
GlaxoSmithKline, LLC. $37,212.50 02/22/2024 Consulting Fee Undisputed 01/23/2026 1116263101 CMS
GlaxoSmithKline, LLC. $25,350.00 05/22/2024 Consulting Fee Undisputed 01/23/2026 1115848451 CMS
GlaxoSmithKline, LLC. $2,437.50 08/29/2024 Consulting Fee Undisputed 01/23/2026 1115985992 CMS
GlaxoSmithKline, LLC. $21,450.00 11/25/2024 Consulting Fee Undisputed 01/23/2026 1116571245 CMS
Janssen Biotech, Inc. $33.94 04/03/2024 Food and Beverage Undisputed 01/23/2026 1078293471 CMS
Janssen Biotech, Inc. $106.67 11/15/2024 Food and Beverage Undisputed 01/23/2026 1078293445 CMS
Janssen Biotech, Inc. $146.61 12/07/2024 Food and Beverage Undisputed 01/23/2026 1078293547 CMS
Janssen Biotech, Inc. $67.29 12/07/2024 Food and Beverage Undisputed 01/23/2026 1078293701 CMS
Janssen Research & Development, LLC $4,280.00 04/18/2024 Consulting Fee Undisputed 01/23/2026 1077589463 CMS
Janssen Research & Development, LLC $18.14 12/02/2024 Food and Beverage Undisputed 01/23/2026 1077587279 CMS
Legend Biotech USA Inc. $25.50 06/10/2024 Travel and Lodging Undisputed 01/23/2026 1131690497 CMS
Legend Biotech USA Inc. $73.73 12/05/2024 Food and Beverage Undisputed 01/23/2026 1131690846 CMS
PFIZER INC. $90.31 04/05/2024 Food and Beverage Undisputed 01/23/2026 1131297499 CMS
PFIZER INC. $80.41 05/15/2024 Food and Beverage Undisputed 01/23/2026 1131326968 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.